Dados B3 › CASN3
CASN3 (Casan): has profit grown?
CASN3 (Casan): in 2025, net income was R$ 387.1 million, up 59% versus 2024 (a profit of R$ 243.0 million); five years earlier (2020), a profit of R$ 112.5 million.
| Year | Profit (loss) | Change |
|---|---|---|
| 2025 | R$ 387.1 million | up 59% |
| 2024 | R$ 243.0 million | up 379% |
| 2023 | R$ 50.7 million | down 45% |
| 2022 | R$ 92.0 million | down 32% |
| 2021 | R$ 134.9 million | up 20% |
| 2020 | R$ 112.5 million | down 6% |
| 2019 | R$ 119.7 million | a turn from loss to profit |
| 2018 | -R$ 119.2 million | a loss in both years |
| 2017 | -R$ 28.5 million | a turn from profit to loss |
| 2016 | R$ 28.4 million | — |
Annual statements (DFP). Profit attributable to controlling shareholders when the company reports it; otherwise total net income. Fact with its source; not investment advice.
Check it yourself
- Open data, no key needed for WEGE3 and with a free key for any company:
https://dadosb3.com/empresas/CASN3/fatos - Every annual figure comes from the DFP filed with the CVM (dados.cvm.gov.br); dividends come from B3.
- The company page shows the account each number came from: CASN3.
Dividends · Debt · Full page · How much it returned · plain text for AI
Numbers on this page are live. Data version 2026-10-01-cfo-metodo-direto · page generated 2026-10-17 16:10 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.
Numbers on this page are live. Data version 2026-10-01-cfo-metodo-direto · page generated 2026-10-17 16:10 UTC. If this does not match /saude, you are reading a cached copy.